These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 12616459)

  • 1. Sex and the renin angiotensin system: implications for gender differences in the progression of kidney disease.
    Sandberg K; Ji H
    Adv Ren Replace Ther; 2003 Jan; 10(1):15-23. PubMed ID: 12616459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The renin-angiotensin-aldosterone system and the kidney: effects on kidney disease.
    Brewster UC; Perazella MA
    Am J Med; 2004 Feb; 116(4):263-72. PubMed ID: 14969655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of gender in the progression of renal disease.
    Silbiger SR; Neugarten J
    Adv Ren Replace Ther; 2003 Jan; 10(1):3-14. PubMed ID: 12616458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
    Vogt L; Kocks MJ; Laverman GD; Navis G
    Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pathophysiologic basis for blocking the renin-angiotensin system in hypertensive patients with renal disease.
    Raij L
    Am J Hypertens; 2005 Apr; 18(4 Pt 2):95S-99S. PubMed ID: 15837551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The renin-angiotensin system and diabetic nephropathy.
    Gurley SB; Coffman TM
    Semin Nephrol; 2007 Mar; 27(2):144-52. PubMed ID: 17418683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aldosterone is a major factor in the progression of renal disease.
    Ibrahim HN; Rosenberg ME; Greene EL; Kren S; Hostetter TH
    Kidney Int Suppl; 1997 Dec; 63():S115-9. PubMed ID: 9407437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of gender on renal disease: the role of the renin angiotensin system.
    Kang AK; Miller JA
    Clin Invest Med; 2003 Feb; 26(1):38-44. PubMed ID: 12659469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Inhibition of the renin-angiotensin system to prevent target organ damage: the "renal continuum"].
    Tislér A
    Orv Hetil; 2003 May; 144(18 Suppl 1):898-901. PubMed ID: 12785234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gender differences in the renin-angiotensin and nitric oxide systems: relevance in the normal and diseased kidney.
    McGuire BB; Watson RW; Pérez-Barriocanal F; Fitzpatrick JM; Docherty NG
    Kidney Blood Press Res; 2007; 30(2):67-80. PubMed ID: 17268203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the renin-angiotensin system in disorders of the urinary tract.
    Brock JW; Hunley TE; Adams MC; Kon V
    J Urol; 1998 Nov; 160(5):1812-9. PubMed ID: 9783965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A clinical approach in regression of glomerulosclerosis.
    Stoian M; Radulian G; Chiţac D; Simion E; Stoica V
    Rom J Intern Med; 2007; 45(2):215-8. PubMed ID: 18333378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender and the renin-angiotensin-aldosterone system.
    Komukai K; Mochizuki S; Yoshimura M
    Fundam Clin Pharmacol; 2010 Dec; 24(6):687-98. PubMed ID: 20608988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the renin-angiotensin system in the pathophysiology, prevention, and treatment of renal impairment in patients with the cardiometabolic syndrome or its components.
    Alpert MA; Govindarajan G; Del Rosario ML; Reisin E
    J Cardiometab Syndr; 2009; 4(1):57-62. PubMed ID: 19245518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for the development and progression of renal diseases in disadvantaged populations: role of the renin-angiotensin system blockade.
    Maione A; Strippoli GF
    Ethn Dis; 2009; 19(1 Suppl 1):S1-86-9. PubMed ID: 19484883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered regulation of renin-angiotensin, endothelin and natriuretic peptide systems in rat kidney with chronic unilateral ureteral obstruction.
    Bae EH; Kim IJ; Park JW; Ma SK; Choi KC; Lee JU; Kim SW
    Urol Int; 2007; 79(2):170-6. PubMed ID: 17851289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progression of renal disease: renoprotective specificity of renin-angiotensin system blockade.
    Griffin KA; Bidani AK
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):1054-65. PubMed ID: 17699327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does concurrent renin-angiotensin-aldosterone blockade in (older) chronic kidney disease patients play a role in the acute renal failure epidemic in US hospitalized patients?--Three cases of severe acute renal failure encountered in a northwestern Wisconsin Nephrology practice.
    Onuigbo MA
    Hemodial Int; 2009 Oct; 13 Suppl 1():S24-9. PubMed ID: 19775421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The renin-angiotensin system, adrenomedullins and urotensin II in the kidney: possible renoprotection via the kidney peptide systems.
    Takahashi K; Hirose T; Mori N; Morimoto R; Kohzuki M; Imai Y; Totsune K
    Peptides; 2009 Aug; 30(8):1575-85. PubMed ID: 19477209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.